Qin Sun

Title: Innovations of Qin Sun in Tumor Treatment

Introduction

Qin Sun is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in tumor treatment and diagnosis. His innovative work has led to the development of a patent that holds promise for cancer therapies.

Latest Patents

Qin Sun holds a patent titled "Use of human NLK gene and associated drugs thereof." This invention discloses the use of the NLK gene for tumor treatment, tumor diagnosis, and drug preparation. The patent further details the construction of an isolated molecule that attenuates the expression of the NLK gene in tumor cells. It also includes cells comprising the isolated molecule and a NLK interference lentivirus, which can specifically inhibit the expression of the NLK gene. This technology has significant implications for effectively treating tumors by inhibiting their growth.

Career Highlights

Qin Sun is associated with Shanghai Genechem Co., Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer therapies and diagnostics. With 1 patent to his name, he is recognized for his contributions to the scientific community.

Collaborations

Qin Sun has collaborated with notable colleagues, including Haixiong Han and Xiangying Zhu. Their combined efforts in research and development have furthered the understanding and application of the NLK gene in medical science.

Conclusion

Qin Sun's innovative work in the field of biotechnology, particularly regarding the NLK gene, showcases his commitment to advancing cancer treatment. His contributions are paving the way for new therapeutic approaches that could significantly benefit patients in the future.